"The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease"

Condition2 Drugs Are Statin and SGLT2i

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age50-80

SponsorFayoum University

About this trial

correlate the serum level of statin and SGLT2i when given as polytherapy with HPLC in ischemic heart failure patients and their laboratory tests (cholesterol, LDL, HDL and TG...)

Eligibility criteria

Qualifiers

we include patients established ischemic heart failure seen by a primary care provider to diagnose ischemic heart disease,

They assessed the use of statin with SGLT2i.

Disqualifiers

We exclude patients with

liver dysfunction.

renal dysfunction.

fungal infection.

Trial design

Treatments tested in this trial

Statin and SGLT2i

Treatment groups

90 Participants

are divided into 3 treatment groups

Sponsors and collaborators

Fayoum University

Lead sponsor

Source ClinicalTrials.gov